Cleveland Alzheimer's Disease Research Center
Cleveland Alzheimer's Disease Research Center
批准号:
10204392
负责人:
JAMES Bruce LEVERENZ
金额:
$16.1万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2023-06-30
关键词:
AdultAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaCOVID-19COVID-19 pandemicClinicClinicalClinical ResearchCognitiveCollectionCommunicationCommunitiesConsentContractsCountryDementiaDiseaseEffectivenessElderlyEnrollmentEthicsEvaluationFaceFoundationsFundingFutureGuidelinesHealth systemHealthcareHeightHeterogeneityImageIndividualInformed ConsentInfrastructureInternationalInterruptionInterviewLegalLewy Body DementiaMeasuresMedicalMedical centerMethodologyMinority EnrollmentNational Institute on AgingNevadaOhioParticipantPathologicPathologyPatientsPersonsPhysiciansPopulationPrion DiseasesProcessPublic HealthQualitative ResearchResearchResearch PersonnelRiskSamplingScienceSpeedStructureSustainable DevelopmentTechnologyTelephoneUnited States National Institutes of HealthUniversitiesUniversity Hospitalsclinical careexperienceimprovedinnovationmild cognitive impairmentpandemic diseasepatient populationprogramsrecruitresearch to practicesupport toolstheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
OVERALL
PROJECT SUMMARY
The Cleveland Alzheimer’s Disease Research Center (CADRC) is a collaborative effort amongst
physicians and investigators from Case Western Reserve University (CWRU), the Cleveland Clinic Foundation
(CCF), the Metro Health System (MHS), University Hospitals (UH), and the Louis Stokes Cleveland VA Medical
Center (LSVA), to establish a National Institute on Aging (NIA) funded Alzheimer’s disease research center. The
CADRC would represent a rich clinical and research community and an estimated 220,000 Ohioans who suffer
from Alzheimer’s disease (AD). Currently there is no Alzheimer’s Disease Research Center in Ohio.
The CADRC will bring together the considerable expertise from the medical and academic communities
in northeast Ohio to focus on one of the largest health care crises facing our country. The CADRC will be focused
on the increasingly recognized clinical and pathologic heterogeneity observed in AD and AD-Related Dementias
(ADRD).
The CADRC will create an infrastructure to help speed up the research efforts of local, national and
international investigators. The CADRC will participate in the national Alzheimer’s Centers program and
contribute to the “big science” possible when centers from around the country collaborate. We will recruit subject
samples that northeast Ohio is well situated to study due to unique regional populations or studies (dementia
with Lewy bodies and rapidly progressive AD identified by the National Prion Disease Pathology Surveillance
Center,) or relevant to our understanding of AD and related dementias (cognitively normal older individuals, AD
and mild cognitive impairment). We will add value to the evaluation of these subject samples by adding biofluid
collection and analysis and cutting edge imaging. Special emphasis will also be placed on enrollment of minority
populations not often well-studied.
We are quite encouraged by the collaborative spirit already demonstrated by those participating in the
CADRC planning from CWRU, CCF, MHS, UH, and LSVA and from the support we have received from the
northeast Ohio community. We believe this is a great opportunity for Ohio to contribute to the greater efforts of
the Alzheimer’s Disease Research Centers program and to improve the treatments for these devastating
disorders.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3233/jad-220929
发表时间:
2023
期刊:
JOURNAL OF ALZHEIMERS DISEASE
影响因子:
4
作者:
[Rao, Stephen M., Galioto, Rachel, Sokolowski, Megan, Pierce, Madelyn, Penn, Lisa, Sturtevant, Anna, Skugor, Blazenka, Anstead, Brent, Leverenz, James B., Schindler, David, Blum, David, Alberts, Jay L., Posk, Lori]
通讯作者:
Posk, Lori
High resolution structural and functional MRI of the hippocampus in young adults with Down syndrome.
DOI:
10.1093/braincomms/fcab088
发表时间:
2021
期刊:
Brain communications
影响因子:
4.8
作者:
[Koenig KA, Oh SH, Stasko MR, Roth EC, Taylor HG, Ruedrich S, Wang ZI, Leverenz JB, Costa ACS]
通讯作者:
Costa ACS
DOI:
10.1002/dad2.12235
发表时间:
2021
期刊:
Alzheimer's & dementia (Amsterdam, Netherlands)
影响因子:
--
作者:
[D'Antonio F, Kane JPM, Ibañez A, Lewis SJG, Camicioli R, Wang H, Yu Y, Zhang J, Ji Y, Borda MG, Kandadai RM, Babiloni C, Bonanni L, Ikeda M, Boeve BF, Leverenz JB, Aarsland D, ISTAART Lewy body dementias Consortia Working Group]
通讯作者:
ISTAART Lewy body dementias Consortia Working Group
Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype.
淀粉样蛋白前体蛋白变体,E665D,与独特的临床和生物标志物表型相关。
DOI:
10.1177/1533317520981225
发表时间:
2021
期刊:
American journal of Alzheimer's disease and other dementias
影响因子:
--
作者:
[Abbatemarco,JustinR, Jones,StephenE, Larvie,Mykol, Bekris,LynnM, Khrestian,MariaE, Krishnan,Kamini, Leverenz,JamesB]
通讯作者:
Leverenz,JamesB
DOI:
10.3390/v13091794
发表时间:
2021-09-08
期刊:
Viruses
影响因子:
--
作者:
[Brennecke N, Cali I, Mok TH, Speedy H, Genomics England Research Consortium, Hosszu LLP, Stehmann C, Cracco L, Puoti G, Prior TW, Cohen ML, Collins SJ, Mead S, Appleby BS]
通讯作者:
Appleby BS
共 6 条
Administrative Core
-
批准号:10474588
-
项目类别:
-
资助金额:$70.6万
-
财政年份:2021
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Cleveland Alzheimers Disease Research Center
-
批准号:10263707
-
项目类别:
-
资助金额:$309.02万
-
财政年份:2021
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:10291600
-
项目类别:
-
资助金额:$9.44万
-
财政年份:2021
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Cleveland Alzheimers Disease Research Center
-
批准号:10474587
-
项目类别:
-
资助金额:$307.85万
-
财政年份:2021
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Administrative Core
-
批准号:10675649
-
项目类别:
-
资助金额:$53.35万
-
财政年份:2021
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Cleveland Alzheimers Disease Research Center
-
批准号:10675648
-
项目类别:
-
资助金额:$307.19万
-
财政年份:2021
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Administrative Core
-
批准号:10263708
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2021
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
International Lewy Body Dementia Conference
-
批准号:9763238
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2019
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Cleveland Alzheimer's Disease Research Center
-
批准号:10170038
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2019
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Cleveland Alzheimer's Disease Research Center
-
批准号:10191903
-
项目类别:
-
资助金额:$25.62万
-
财政年份:2019
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:9272232
-
项目类别:
-
资助金额:$98.03万
-
财政年份:2016
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:9769915
-
项目类别:
-
资助金额:$136.56万
-
财政年份:2016
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:10022167
-
项目类别:
-
资助金额:$107.17万
-
财政年份:2016
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Dementia with Lewy Bodies Consortium
-
批准号:9357401
-
项目类别:
-
资助金额:$121.84万
-
财政年份:2016
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
EDUCATION AND INFORMATION CORE
-
批准号:8441004
-
项目类别:
-
资助金额:$29.37万
-
财政年份:1997
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Clinical Core
-
批准号:8327238
-
项目类别:
-
资助金额:$69.05万
-
财政年份:--
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
Clinical Core
-
批准号:8132237
-
项目类别:
-
资助金额:$81.96万
-
财政年份:--
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
EDUCATION AND INFORMATION CORE
-
批准号:8459481
-
项目类别:
-
资助金额:$26.73万
-
财政年份:--
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
EDUCATION AND INFORMATION CORE
-
批准号:8441082
-
项目类别:
-
资助金额:$28.62万
-
财政年份:--
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
EDUCATION AND INFORMATION CORE
-
批准号:8014545
-
项目类别:
-
资助金额:$29.0万
-
财政年份:--
-
负责人:JAMES Bruce LEVERENZ
-
依托单位:
海外基金